News Lampalizumab Keeps Intraocular Pressure Steady by Medscape • 2024/06/26 • 0 Comments Monthly intravitreous injections of 0.1 mL of lampalizumab over 1 year were associated with a low risk for adverse events associated with intraocular pressure in patients with geographic atrophy. Medscape Medical News